I agree that this site is using cookies. You can find further informations here.
X
Vertongen, P.
42  results:
Search for persons X
?
1

Status of the ITER vacuum vessel construction:

Choi, C.H. ; Sborchia, C. ; Ioki, K....
Fusion Engineering and Design.  89 (2014)  7-8 - p. 1859-1863 , 2014
Link: https://doi.org/10.1016/..
 
?
2

Lysine 195 and aspartate 196 in the first extracellular loo..:

Langer, I ; Vertongen, P ; Perret, J..
Neuropharmacology.  44 (2003)  1 - p. 125-131 , 2003
Link: https://doi.org/10.1016/..
 
?
3

Two tyrosine residues in the first transmembrane helix of t..:

Perret, J ; Vertongen, P ; Solano, R M...
British Journal of Pharmacology.  136 (2002)  7 - p. 1042-1048 , 2002
Link: https://doi.org/10.1038/..
 
?
4

Vasoactive intestinal peptide (VIP) stimulates [Ca2+]iand c..:

Langer, I. ; Perret, J. ; Vertongen, P...
Cell Calcium.  30 (2001)  4 - p. 229-234 , 2001
Link: https://doi.org/10.1054/..
 
?
5

Mutational analysis of the human vasoactive intestinal pept..:

Vertongen, P ; Solano, R M ; Perret, J...
British Journal of Pharmacology.  133 (2001)  8 - p. 1249-1254 , 2001
Link: https://doi.org/10.1038/..
 
?
6

Proline residue 280 in the second extracellular loop (EC2) ..:

Vertongen, P. ; Solano, R.M. ; Juarranz, M.G....
Peptides.  22 (2001)  9 - p. 1363-1370 , 2001
Link: https://doi.org/10.1016/..
 
?
7

Comparison between vasoactive intestinal polypeptide and pi..:

Vertongen, P ; De Clerck, P ; Fournet, J.-C...
Neuropeptides.  31 (1997)  5 - p. 409-413 , 1997
Link: https://doi.org/10.1016/..
 
?
8

Conversion of atrial fibrillation to sinus rhythm and rate ..:

Jordaens, L. ; Trouerbach, J. ; Calle, P....
European Heart Journal.  18 (1997)  4 - p. 643-648 , 1997
Link: https://doi.org/10.1093/..
 
?
9

VIP and pituitary adenylate cyclase activating polypeptide ..:

Vertongen, P ; Camby, I ; Darro, F..
Neuropeptides.  30 (1996)  5 - p. 491-496 , 1996
Link: https://doi.org/10.1016/..
 
?
10

Relative quantitative analysis of glucagon receptor mRNA in..:

Svoboda, M. ; Tastenoy, M. ; Vertongen, P..
Molecular and Cellular Endocrinology.  105 (1994)  2 - p. 131-137 , 1994
Link: https://doi.org/10.1016/..
 
?
11

Pituitary adenylate cyclase-activating polypeptide receptor..:

Vertongen, P ; Ciccarelli, E ; Woussen-Colle, M C...
Endocrinology.  135 (1994)  4 - p. 1537-1542 , 1994
Link: https://doi.org/10.1210/..
 
?
12

Expression of pituitary adenylate cyclase activating polype..:

Robberecht, P. ; Woussen-Colle, M.-C. ; Vertongen, P....
Peptides.  15 (1994)  4 - p. 661-665 , 1994
Link: https://doi.org/10.1016/..
 
?
13

Receptors for pituitary adenylate cyclase activating peptid..:

Robberecht, P ; Vertongen, P ; Velkeniers, B...
The Journal of Clinical Endocrinology & Metabolism.  77 (1993)  5 - p. 1235-1239 , 1993
Link: https://doi.org/10.1210/..
 
?
14

Ontogenic development of PACAP and PACAP receptors in rat b..:

Vertongen, P ; Hou, X ; Robberecht, P..
Regulatory Peptides.  40 (1992)  2 - p. 271 , 1992
Link: https://doi.org/10.1016/..
 
?
15

Two tyrosine residues in the first transmembrane helix of t..:

Perret, J ; Vertongen, P ; Solano, R M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573430.  , 2002
Link: http://www.ncbi.nlm.nih...
 
1-15